RecruitingNCT03217656

The Jiaxing Birth Cohort in China


Sponsor

Zhejiang University

Enrollment

500,000 participants

Start Date

Jan 1, 1999

Study Type

OBSERVATIONAL

Conditions

Summary

The Jiaxing Birth Cohort (JBC) is the largest prospective cohort study to explore prenatal risk factors, early life feeding practice and growth pattern/ adiposity in Chinese children.Between 1999 and 2013, 338 413 mother-child pairs were recruited in Jiaxing area in south-east China.Children of the recruited women were followed up at 1-2, 3, 6, 9 and 12 months of age, and subsequently followed up every 6 months to 36 months of age (toddler stage), and every year to 6-7 years of age before they went to school (pre-school stage). Follow-up rate was 70.8% at the toddler stage and 68.9% at the pre-school stage up to June 2013.


Eligibility

Plain Language Summary

Simplified for easier understanding

This is a long-term birth cohort study based in Jiaxing, China, that follows pregnant women and their children over time to understand how factors during pregnancy affect the health of mothers and children. **You may be eligible if...** - You are a pregnant woman who had a prenatal visit at a participating hospital in the Jiaxing area - Your baby was born alive at one of the local hospitals or clinics **You may NOT be eligible if...** - You do not wish to participate - Your baby was stillborn - You moved out of the Jiaxing area during your pregnancy - You did not complete follow-up visits during your pregnancy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

Locations(1)

Zhejiang University

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03217656


Related Trials